Mylan Investigations Mount as West Virginia Opens Fraud ProbeBy and
West Virginia AG seeks court order on rebate documents
Morrisey calls EpiPen’s 500 percent price hike ‘outrageous’
Mylan NV, already under fire from patients over the rising price of its EpiPen allergy shots, is facing a growing number of questions from lawmakers and law enforcement after the state of West Virginia launched a Medicaid fraud investigation into the drugmaker’s pricing Tuesday.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.